Data from EMA (European Medicines Agency) - Curated by Toby Galbraith - Last updated 11 July 2017

Indication(s)

Neuropathic pain
Pregabalin Accord is indicated for the treatment of peripheral and central neuropathic pain in adults.

Epilepsy
Pregabalin Accord is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Generalised anxiety disorder
Pregabalin Accord is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Obstructive Pulmonary Disease (COPD)

View highlights from recent congresses presented in new expert videos with leading physicians.

+ 3 more

Visit Chronic Obstructive Pulmonary Disease (COPD)

Prostate Cancer

How can you balance the harmful effects of treatment with control of prostate cancer growth in otherwise healthy patients?

+ 1 more

Visit Prostate Cancer

Related Content

More information

Category Value
Agency product number EMEA/H/C/004024
Orphan designation No
Date First Approved 28-08-2015
Type Medicinal product subject to medical prescription
Marketing authorisation holder Accord Healthcare Limited